Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Oct 28, 2026 · Filed Oct 30, 2026
A Medifast director paid $66K out of pocket for Medifast shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$66,093
Shares × reported transaction price
$25K–$100K
+0.8%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 2 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 8 earlier confirmed purchases
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
2 days after results of Oct 26, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $12.28 on Oct 28, 2026, 30% above its 52-week low and 7% below its high, after a 3% rise over the previous 30 trading days
52-week range $9.45 (Jul 23, 2026) to $13.15 (May 28, 2026), 76% of the way up, from 251 adjusted closes. 30 trading days earlier: $11.96 on Sep 16, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
The first open-market purchase by any MED insider since Jun 2025. Parsa Kiai's first open-market purchase of MED in filings since 2006
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +6.7% | +0.1% | +6.6% |
Past results only. Not a forecast.
Insider buying
Traded Nov 4 · filed 2 days later
A Medifast director paid $8.6K out of pocket for Medifast shares.
Insider buying
First insider buy since Jun 2025Traded Oct 28 · filed 2 days later
A Medifast director paid $1.9K out of pocket for Medifast shares.
Parsa Kiai, Director's past purchases, 30 days after disclosure: 3 buys, median −3.0 pts vs S&P 500, beat it 0 of 3 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
